Search Results

There are 25747 results for: content related to: Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study

  1. The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy

    European Journal of Neurology

    Volume 18, Issue 6, June 2011, Pages: 919–924, A. B. Bohn, L. Nederby, T. Harbo, A. Skovbo, T. Vorup-Jensen, J. Krog, J. Jakobsen and M. E. Hokland

    Article first published online : 11 JAN 2011, DOI: 10.1111/j.1468-1331.2010.03333.x

  2. No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment

    European Journal of Neurology

    Volume 9, Issue 6, November 2002, Pages: 565–572, M. Lewańska, M. Siger-Zajdel and K. Selmaj

    Article first published online : 9 DEC 2002, DOI: 10.1046/j.1468-1331.2002.00500.x

  3. Education, occupation, and perception of health amongst previous polio patients compared to their siblings

    European Journal of Neurology

    Volume 9, Issue 3, May 2002, Pages: 233–241, E. Farbu and N. E. Gilhus

    Article first published online : 1 MAY 2002, DOI: 10.1046/j.1468-1331.2002.00390.x

  4. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial

    European Journal of Neurology

    Volume 16, Issue 5, May 2009, Pages: 631–638, T. Harbo, H. Andersen, A. Hess, K. Hansen, S. H. Sindrup and J. Jakobsen

    Article first published online : 19 FEB 2009, DOI: 10.1111/j.1468-1331.2009.02568.x

  5. Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies

    European Journal of Neurology

    Volume 14, Issue 10, October 2007, Pages: 1147–1153, S. Matà, S. Corzani, R. Biagiotti, S. Piacentini, G. Siracusa, M. G. Giudizi, M. D. Mastio, W. Borsini, R. Taiuti, A. Vultaggio, S. Sorbi and E. Maggi

    Article first published online : 18 SEP 2007, DOI: 10.1111/j.1468-1331.2007.01929.x

  6. Treatment of functional limitations at the knee in ambulatory children with cerebral palsy

    European Journal of Neurology

    Volume 8, Issue s5, November 2001, Pages: 59–74, H. G. Chambers

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00039.x

  7. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins

    European Journal of Neurology

    Volume 13, Issue 12, December 2006, Pages: 1359–1363, C. Trebst, K. Brunhorn, M. Lindner, A. Windhagen and M. Stangel

    Article first published online : 17 OCT 2006, DOI: 10.1111/j.1468-1331.2006.01521.x

  8. Intravenous immunoglobulin G for the treatment of relapsing–remitting multiple sclerosis: a meta-analysis

    European Journal of Neurology

    Volume 9, Issue 6, November 2002, Pages: 557–563, P. S. Sorensen, F. Fazekas and M. Lee

    Article first published online : 9 DEC 2002, DOI: 10.1046/j.1468-1331.2002.00501.x

  9. The role of IL-12 and TNF-α in AIDP and AMAN

    European Journal of Neurology

    Volume 15, Issue 10, October 2008, Pages: 1100–1105, H. Deng, X. Yang, T. Jin, J. Wu, L.-S. Hu, M. Chang, X.-J. Sun, A. Adem, B. Winblad and J. Zhu

    Article first published online : 20 AUG 2008, DOI: 10.1111/j.1468-1331.2008.02261.x

  10. Cost–utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy

    European Journal of Neurology

    Volume 10, Issue 6, November 2003, Pages: 687–694, Paul McCrone, Daniel Chisholm, Martin Knapp, Richard Hughes, Giancarlo Comi, Marinos C. Dalakas, Isabel Illa, Costas Kilindireas, Eduardo Nobile-Orazio, Anthony Swan, Peter Van den Bergh, Hugh J. Willison and the INCAT Study Group

    Article first published online : 22 OCT 2003, DOI: 10.1046/j.1351-5101.2003.00701.x

  11. Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature

    European Journal of Neurology

    Volume 10, Issue 4, July 2003, Pages: 367–372, R. Zaidan, M. Al Moallem, B. A. Wani, A. R. Shameena, A. R. Al Tahan, A. K. Daif and S. Al Rajeh

    Article first published online : 19 JUN 2003, DOI: 10.1046/j.1468-1331.2003.00542.x

  12. Disorders in intentional gestural organization in Alzheimer’s disease: combined or selective impairment of the conceptual and production systems?

    European Journal of Neurology

    Volume 8, Issue 6, November 2001, Pages: 629–641, A. Blondel, B. Desgranges, V. De La Sayette, S. Schaeffer, K. Benali, B. Lechevalier, F. Viader and F. Eustache

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00318.x

  13. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

    European Journal of Neurology

    Volume 17, Issue s2, August 2010, Pages: 9–37, S. C. Love, I. Novak, M. Kentish, K. Desloovere, F. Heinen, G. Molenaers, S. O’Flaherty and H. K. Graham

    Article first published online : 15 JUL 2010, DOI: 10.1111/j.1468-1331.2010.03126.x

  14. Susac syndrome: clinical characteristics and treatment in 29 new cases

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 800–811, F. J. Mateen, A. Y. Zubkov, R. Muralidharan, J. E. Fugate, F. J. Rodriguez, J. L. Winters and G. W. Petty

    Article first published online : 4 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03627.x

  15. Outcome measures of spasticity

    European Journal of Neurology

    Volume 9, Issue s1, May 2002, Pages: 10–16, G. R. Johnson

    Article first published online : 25 MAR 2002, DOI: 10.1046/j.1468-1331.2002.0090s1010.x

  16. Cost of disorders of the brain in Europe

    European Journal of Neurology

    Volume 12, Issue s1, June 2005, Pages: 1–27, Patrik Andlin-Sobocki, Bengt Jönsson, Hans-Ulrich Wittchen and Jes Olesen

    Article first published online : 5 MAY 2005, DOI: 10.1111/j.1468-1331.2005.01202.x

  17. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period

    European Journal of Neurology

    Volume 8, Issue 5, September 2001, Pages: 463–469, E. G. Celius and B. Vandvik

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00269.x

  18. Familial migraine with and without aura: clinical characteristics and co-occurrence

    European Journal of Neurology

    Volume 8, Issue 5, September 2001, Pages: 441–449, M. Kallela, M. Wessman, H. Havanka, A. Palotie and M. Färkkilä

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00260.x

  19. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial

    European Journal of Neurology

    Volume 8, Issue s5, November 2001, Pages: 50–58, S. C. Love, J. P. Valentine, E. M. Blair, C. J. Price, J. H. Cole and P. J. Chauvel

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00038.x

  20. Depletion of Vβ5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis

    European Journal of Neurology

    Volume 9, Issue 2, March 2002, Pages: 153–164, T. Olsson, C. Edenius, M. Ferm, P. Samuelson, A. Torrång, E. Wallström, M. Khademi, M. Andersson and L. Årfors

    Article first published online : 7 MAR 2002, DOI: 10.1046/j.1468-1331.2002.00370.x